UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLC

JTO clinical and research reports, 2023-01, Vol.4 (1), p.100431, Article 100431

2023

Volltextzugriff (PDF)

Meta-analysis of 701 published cases of sinonasal neuroendocrine carcinoma: The importance of differentiation grade in determining treatment strategy

Oral oncology, 2016-12, Vol.63, p.1-9

2016

Volltextzugriff (PDF)

Characterization of MET Exon 14 Skipping Alterations (in NSCLC) and Identification of Potential Therapeutic Targets Using Whole Transcriptome Sequencing

JTO clinical and research reports, 2022-09, Vol.3 (9), p.100381-100381, Article 100381

2022

Volltextzugriff (PDF)

Revolving Door of Histologic Transformation—Tumor Heterogeneity Complicating the Management of EGFR-Mutated Lung Adenocarcinoma: A Case of Jekyll and Hyde

JTO clinical and research reports, 2021-02, Vol.2 (2), p.100128, Article 100128

2021

Volltextzugriff (PDF)

Coronavirus Disease 2019 Outcomes, Patient Vaccination Status, and Cancer-Related Delays During the Omicron Wave: A Brief Report From the TERAVOLT Analysis

JTO clinical and research reports, 2022-08, Vol.3 (8), p.100335-100335, Article 100335

2022

Volltextzugriff (PDF)

Survival Patterns in Elderly Head and Neck Squamous Cell Carcinoma Patients Treated With Definitive Radiation Therapy

International journal of radiation oncology, biology, physics, 2017-07, Vol.98 (4), p.793-801

2017

Volltextzugriff (PDF)

Fewer head and neck cancer diagnoses and faster treatment initiation during COVID-19 in 2020: A nationwide population-based analysis

Radiotherapy and oncology, 2022-02, Vol.167, p.42-48

2022

Volltextzugriff (PDF)

An alternative inhibitor overcomes resistance caused by a mutation of the epidermal growth factor receptor

Cancer research (Chicago, Ill.), 2005-08, Vol.65 (16), p.7096-7101

2005

Volltextzugriff (PDF)

COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials

Nature reviews. Clinical oncology, 2021-05, Vol.18 (5), p.313-319

2021

Volltextzugriff (PDF)

HHLA2, a New Immune Checkpoint Member of the B7 Family, Is Widely Expressed in Human Lung Cancer and Associated with EGFR Mutational Status

Clinical cancer research, 2017-02, Vol.23 (3), p.825-832

2017

Volltextzugriff (PDF)

Impact of sarcopenia on survival and late toxicity in head and neck cancer patients treated with radiotherapy

Radiotherapy and oncology, 2020-06, Vol.147, p.103-110

2020

Volltextzugriff (PDF)

Effects of Erlotinib in EGFR Mutated Non-Small Cell Lung Cancers with Resistance to Gefitinib

Clinical cancer research, 2008-11, Vol.14 (21), p.7060-7067

2008

Volltextzugriff (PDF)

Biomarker testing in cancer management- can one size fit all?

British journal of cancer, 2022-10, Vol.127 (7), p.1177-1179

2022

Volltextzugriff (PDF)

Cost-utility and cost-effectiveness of a guided self-help head and neck exercise program for patients treated with total laryngectomy: Results of a multi-center randomized controlled trial

Oral oncology, 2021-06, Vol.117, p.105306-105306, Article 105306

2021

Volltextzugriff (PDF)

Relation Between Age, Comorbidity, and Complications in Patients Undergoing Major Surgery for Head and Neck Cancer

Annals of surgical oncology, 2014-03, Vol.21 (3), p.963-970

2014

Volltextzugriff (PDF)

Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic Profiling

Journal of thoracic oncology, 2017-06, Vol.12 (6), p.932-942

2017

Volltextzugriff (PDF)

Pembrolizumab Plus Chemotherapy in Squamous Non-Small-Cell Lung Cancer: 5-Year Update of the Phase III KEYNOTE-407 Study

Journal of clinical oncology, 2023-04, Vol.41 (11), p.1999-2006

2023

Volltextzugriff (PDF)

Incidental findings during the diagnostic work-up in the head and neck cancer pathway: Effects on treatment delay and survival

Oral oncology, 2021-07, Vol.118, p.105350-105350, Article 105350

2021

Volltextzugriff (PDF)

Response to “Head and neck cancer diagnoses and faster treatment initiation during COVID-19: Correspondence”

Radiotherapy and oncology, 2022-04, Vol.169, p.146-147

2022

Volltextzugriff (PDF)

Effectiveness of a guided self-help exercise program tailored to patients treated with total laryngectomy: Results of a multi-center randomized controlled trial

Oral oncology, 2020-04, Vol.103, p.104586-104586, Article 104586

2020

Volltextzugriff (PDF)

Frailty is associated with decline in health-related quality of life of patients treated for head and neck cancer

Oral oncology, 2020-12, Vol.111, p.105020-105020, Article 105020

2020

Volltextzugriff (PDF)

Patient-Reported Toxicity and Quality-of-Life Profiles in Patients With Head and Neck Cancer Treated With Definitive Radiation Therapy or Chemoradiation

International journal of radiation oncology, biology, physics, 2021-10, Vol.111 (2), p.456-467

2021

Volltextzugriff (PDF)

Tumor Markers and Their Prognostic Value in Sinonasal ITAC/Non-ITAC

Cancers, 2023-06, Vol.15 (12), p.3201

2023

Volltextzugriff (PDF)

Impact of sarcopenia on acute radiation-induced toxicity in head and neck cancer patients

Radiotherapy and oncology, 2022-05, Vol.170, p.122-128

2022

Volltextzugriff (PDF)

Phase II Study of Maintenance Pembrolizumab in Patients with Extensive-Stage Small Cell Lung Cancer (SCLC)

Journal of thoracic oncology, 2018-09, Vol.13 (9), p.1393-1399

2018

Volltextzugriff (PDF)

1 – 25 von 107

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(102)
Mit Volltextzugriff
(97)

Publikationsform

Artikel
(107)

Sprache

Englisch
(107)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLC

Meta-analysis of 701 published cases of sinonasal neuroendocrine carcinoma: The importance of differentiation grade in determining treatment strategy

Characterization of MET Exon 14 Skipping Alterations (in NSCLC) and Identification of Potential Therapeutic Targets Using Whole Transcriptome Sequencing

Revolving Door of Histologic Transformation—Tumor Heterogeneity Complicating the Management of EGFR-Mutated Lung Adenocarcinoma: A Case of Jekyll and Hyde

Coronavirus Disease 2019 Outcomes, Patient Vaccination Status, and Cancer-Related Delays During the Omicron Wave: A Brief Report From the TERAVOLT Analysis

Survival Patterns in Elderly Head and Neck Squamous Cell Carcinoma Patients Treated With Definitive Radiation Therapy

Fewer head and neck cancer diagnoses and faster treatment initiation during COVID-19 in 2020: A nationwide population-based analysis

An alternative inhibitor overcomes resistance caused by a mutation of the epidermal growth factor receptor

COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials

HHLA2, a New Immune Checkpoint Member of the B7 Family, Is Widely Expressed in Human Lung Cancer and Associated with EGFR Mutational Status

Impact of sarcopenia on survival and late toxicity in head and neck cancer patients treated with radiotherapy

Effects of Erlotinib in EGFR Mutated Non-Small Cell Lung Cancers with Resistance to Gefitinib

Biomarker testing in cancer management- can one size fit all?

Cost-utility and cost-effectiveness of a guided self-help head and neck exercise program for patients treated with total laryngectomy: Results of a multi-center randomized controlled trial

Relation Between Age, Comorbidity, and Complications in Patients Undergoing Major Surgery for Head and Neck Cancer

Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic Profiling

Pembrolizumab Plus Chemotherapy in Squamous Non-Small-Cell Lung Cancer: 5-Year Update of the Phase III KEYNOTE-407 Study

Incidental findings during the diagnostic work-up in the head and neck cancer pathway: Effects on treatment delay and survival

Response to “Head and neck cancer diagnoses and faster treatment initiation during COVID-19: Correspondence”

Effectiveness of a guided self-help exercise program tailored to patients treated with total laryngectomy: Results of a multi-center randomized controlled trial

Frailty is associated with decline in health-related quality of life of patients treated for head and neck cancer

Patient-Reported Toxicity and Quality-of-Life Profiles in Patients With Head and Neck Cancer Treated With Definitive Radiation Therapy or Chemoradiation

Tumor Markers and Their Prognostic Value in Sinonasal ITAC/Non-ITAC

Impact of sarcopenia on acute radiation-induced toxicity in head and neck cancer patients

Phase II Study of Maintenance Pembrolizumab in Patients with Extensive-Stage Small Cell Lung Cancer (SCLC)

Aktive Filter

Suchergebnisse filtern